You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for Patent: 9,649,364


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,649,364
Title:Methods for producing stable therapeutic formulations in aprotic polar solvents
Abstract: Certain embodiments are directed to a formulation of a therapeutic agent, as well as a method of making such a formulation, comprising at least one therapeutic agent dissolved in an aprotic polar solvent system comprising at least one ionization stabilizing excipient in a concentration sufficient to impart physical and chemical stability to the therapeutic agent.
Inventor(s): Prestrelski; Steven (San Diego, CA), Sandoval; Michael (Austin, TX), Donovan; Martin (Austin, TX)
Assignee: XERIS PHARMACEUTICALS, INC. (Austin, TX)
Application Number:15/136,650
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Compound;

Drugs Protected by US Patent 9,649,364

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Xeris GVOKE HYPOPEN glucagon SOLUTION;SUBCUTANEOUS 212097-003 Sep 10, 2019 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y TREATMENT OF SEVERE HYPOGLYCEMIA ⤷  Sign Up
Xeris GVOKE HYPOPEN glucagon SOLUTION;SUBCUTANEOUS 212097-004 Sep 10, 2019 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y TREATMENT OF SEVERE HYPOGLYCEMIA ⤷  Sign Up
Xeris GVOKE PFS glucagon SOLUTION;SUBCUTANEOUS 212097-001 Sep 10, 2019 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y TREATMENT OF SEVERE HYPOGLYCEMIA ⤷  Sign Up
Xeris GVOKE PFS glucagon SOLUTION;SUBCUTANEOUS 212097-002 Sep 10, 2019 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y TREATMENT OF SEVERE HYPOGLYCEMIA ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,649,364

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2016326749 ⤷  Sign Up
Brazil 112018005800 ⤷  Sign Up
Canada 2999404 ⤷  Sign Up
Canada 3204984 ⤷  Sign Up
China 108135980 ⤷  Sign Up
China 115531523 ⤷  Sign Up
Eurasian Patent Organization 201890704 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.